Skip to content

A Study on Personalized Post-Surgery Treatment for Bladder Cancer Patients

Personalized Adjuvant Therapy Following Radical Cystectomy for Bladder Cancer: A Prospective Cohort Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500108686
Enrollment
Unknown
Registered
2025-09-03
Start date
2025-10-01
Completion date
Unknown
Last updated
2025-09-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder cancer

Interventions

Observation Group:NA

Sponsors

Zhejiang Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Patients with complete baseline clinical data and postoperative adjuvant treatment information (e.g., chemotherapy, immunotherapy, etc.); 2.Pathologically confirmed diagnosis of malignant bladder tumor, including muscle-invasive bladder cancer (MIBC) and high-risk non-muscle-invasive bladder cancer (HR-NMIBC), confirmed preoperatively or postoperatively; 3.Have undergone radical cystectomy and are either planned to receive or currently receiving adjuvant therapy; 4.Age >=18 years, no restriction on sex; 5.No history of active malignant tumors at other anatomical sites.

Exclusion criteria

Exclusion criteria: 1.Patients without bladder cancer or those who have not undergone radical cystectomy; 2.Patients who have not received or have declined adjuvant therapy; 3.Patients with a history of other malignant tumors that are currently active; 4.Patients with severe cardiopulmonary dysfunction, liver or renal failure, or other major comorbidities that render them unfit for adjuvant therapy; 5.Patients who are unable to comply with follow-up or complete required clinical assessments.

Design outcomes

Primary

MeasureTime frame
Recurrence-Free Survival, RFS;

Countries

China

Contacts

Public ContactQi Zhang

Zhejiang Provincial People's Hospital

clinic@126.com+86 13858019285

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026